In the US, the Food and Drug Administration (FDA) has announced in the Federal Register that it is extending the comment period on proposed fees for reinspections, recalls and importer reinspection fees.
The comment period was originally supposed to come to an end on 31 October, The Packer reported.
In August, the FDA had said that it was gathering comments on establishing fees for fiscal 2012 and providing the fee schedule for 2012.
No comments:
Post a Comment